Get the Stockscreener App
2.21
0.45%
-0.00
Seer Inc stock is traded at $2.21, with a volume of 9,378.
It is down -0.45% in the last 24 hours and up +7.32% over the past month.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$2.21
Open:
$2.23
24h Volume:
9,378
Relative Volume:
0.07
Market Cap:
$115.05M
Revenue:
$14.18M
Net Income/Loss:
$-82.66M
P/E Ratio:
-1.70
EPS:
-1.3
Net Cash Flow:
$-50.80M
1W Performance:
-2.65%
1M Performance:
+7.32%
6M Performance:
+10.00%
1Y Performance:
+11.11%
1-Day Range:
$2.20
$2.247
1-Week Range:
$2.20
$2.38
52-Week Range:
$1.62
$2.625
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
2.20 | 124.51M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.58 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.01 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
544.91 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.67 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
325.17 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Will Seer Inc. price bounce be sustainableInflation Watch & AI Forecasted Stock Moves - newser.com
Using Bollinger Bands to evaluate Seer Inc.Portfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Can Seer Inc. stock hit record highs againWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics 2025 - Investing News Network
Seer to showcase proteomics platform at ASHG 2025 annual meeting By Investing.com - Investing.com Nigeria
Seer, Inc. to Showcase Proteomic Innovations at ASHG 2025 Annual Meeting - Quiver Quantitative
Seer Highlights How Proteomics Complements Genomics to - GlobeNewswire
CoLab Oct 16 — Seer’s Proteograph Drives Proteogenomic Insights at ASHG 2025 (Oct 14–18) - Stock Titan
What indicators show strength in Seer Inc.Share Buyback & High Accuracy Trade Alerts - newser.com
Seer's (SEER) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Smart tools for monitoring Seer Inc.’s price actionTrade Volume Summary & Growth Focused Entry Point Reports - newser.com
Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study With Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults - 富途牛牛
Using Ichimoku Cloud for Seer Inc. technicalsPortfolio Update Report & Weekly Setup with ROI Potential - newser.com
Analyzing Seer Inc. with risk reward ratio charts2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
What analysts say about Seer Inc stockInstitutional Buying Trends & Superior Trading Ideas - earlytimes.in
Has Seer Inc. formed a bullish divergence2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Heatmap analysis for Seer Inc. and competitors2025 Pullback Review & Stock Portfolio Risk Management - newser.com
Seer, Inc.(NasdaqGS: SEER) dropped from S&P Global BMI Index - MarketScreener
Fund Flows: Can Seer Inc be recession proofShare Buyback & AI Enhanced Trading Signals - خودرو بانک
Visual trend scoring systems applied to Seer Inc.Portfolio Value Report & Free Accurate Trade Setup Notifications - newser.com
Is Seer Inc. reversing from oversold territoryJuly 2025 Spike Watch & Daily Oversold Bounce Ideas - newser.com
using ichimoku cloud for seer inc. technicalsInsider Buying & Accurate Entry/Exit Alerts - newser.com
S P Trends: Will Seer Inc outperform the market in YEAR2025 Key Highlights & Real-Time Volume Analysis Alerts - خودرو بانک
Will a bounce in Seer Inc. offer an exitTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
Owning 41% shares,institutional owners seem interested in Seer, Inc. (NASDAQ:SEER), - Yahoo Finance
Jacobs Levy Equity Management Inc. Has $614,000 Holdings in Seer, Inc. $SEER - MarketBeat
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seer Inc Stock (SEER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
| Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
2.20%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):